Skip to main content
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.700
+0.050 (1.37%)
At close: Aug 13, 2025, 4:00 PM
3.950
+0.250 (6.76%)
After-hours: Aug 13, 2025, 4:00 PM EDT

TriSalus Life Sciences Revenue

TriSalus Life Sciences had revenue of $11.21M in the quarter ending June 30, 2025, with 52.27% growth. This brings the company's revenue in the last twelve months to $35.99M, up 45.50% year-over-year. In the year 2024, TriSalus Life Sciences had annual revenue of $29.43M with 58.99% growth.

Revenue (ttm)
$35.99M
Revenue Growth
+45.50%
P/S Ratio
2.93
Revenue / Employee
$327,182
Employees
110
Market Cap
184.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 20205.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings

TLSI News

More News